LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue
+11.3%
EPS
−14.3%
Free cash flow
−25.8%
Total debt
+0.53%

Quarter to September 2026, against a year earlier

82.87 5.05 −5.74%
Market cap
$1.9B
P/E
29.7×
Fwd P/E
28.2×
Dividend yield
1.15%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100

LeMaitre Vascular, Inc. (LMAT) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a EV/Sales of 6.2×. Over the past ten years it has ranged from 1.4× (January 2015) to 10.9× (November 2024); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.6× (25.14%)
FY2024 8.8× 45.65%
FY2023 6.1× 4.91%
FY2022 5.8× (11.71%)
FY2021 6.5× 1.80%
FY2020 6.4× 8.31%
FY2019 5.9× 52.25%
FY2018 3.9× (28.35%)
FY2017 5.4× 9.64%
FY2016 5.0× 39.27%

Quarterly newest first

Period EV/Sales Change
Sep 2026 6.2× (18.14%)
Jun 2026 7.6× (15.31%)
Mar 2026 9.0× 35.52%
Dec 2025 6.6× (12.18%)
43 more quarters

Against its own ten years

Low 1.4× High 10.9×
Ten-year median 6.1×
Current reading's percentile 50

EV/Sales against peers

Company EV/Sales
XRAY DENTSPLY SIRONA Inc. compare 1.1×
AZTA Azenta, Inc. compare 2.3×
STVN Stevanato Group S.p.A. compare 2.8×
WRBY Warby Parker Inc. compare 3.2×
STAA STAAR Surgical Company compare 3.5×
ATRC AtriCure, Inc. compare 4.9×
LMAT LeMaitre Vascular, Inc. 6.2×
KMTS Kestra Medical Technologies, Ltd. compare 14.2×
PLSE Pulse Biosciences, Inc compare 2,578×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LMAT